title: Tolerance of young infants to a single, large dose of vitamin A: a randomized community trial in Nepal.
abstract: A randomized, double-masked trial was carried out in rural Nepal to investigate the incidence and severity of acute side-effects among neonates ( < 1 month of age) and infants aged 1-6 months who received a large, oral dose of vitamin A (15,000 retinol equivalents (RE) (50,000 IU) and 30,000 RE (100,000 IU), respectively) or placebo (75 RE (250 IU) and 150 RE (500 IU), respectively) in oil. Infants (vitamin A group, n = 1461; controls, n = 1379) were assessed for vomiting, loose stools, fever, and irritability during the 24 hours before and after dosing. Fontanelles were palpated 24 hours after dosing. Neonates exhibited no excess risk of adverse side-effects after receiving 15,000 RE. Compared with controls the older infants who ingested 30,000 RE had a 1.6% excess rate of vomiting (95% confidence interval (CI): 0.2-3.0%) and a 0.5% excess rate (95% CI: -0.1 to 1.1%) in the occurrence of bulging fontanelles. There were no other significant differences in the older infants. The controlled, periodic distribution of a single 15,000 RE dose of vitamin A therefore confers no apparent acute risk to young infants; a 30,000 RE dose is associated with a minimum risk of transient, acute side-effects.
authors: School of Medicine, Johns Hopkins University, Baltimore, MD.
authors: K P
authors: KP
authors: West
authors: S K
authors: SK
authors: Khatry
authors: S C
authors: SC
authors: LeClerq
authors: R
authors: R
authors: Adhikari
authors: L
authors: L
authors: See
authors: J
authors: J
authors: Katz
authors: S R
authors: SR
authors: Shrestha
authors: E K
authors: EK
authors: Pradhan
authors: R P
authors: RP
authors: Pokhrel
authors: A
authors: A
authors: Sommer
mesh_terms: D000367:Age Factors; D003967:Diarrhea / Q000139:chemically induced; D004305:Dose-Response Relationship, Drug; D004311:Double-Blind Method; D005334:Fever / Q000139:chemically induced; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D009390:Nepal; D009974:Orthomolecular Therapy / Q000009:adverse effects; D014801:Vitamin A / Q000008:administration & dosage / Q000009:adverse effects*; D014839:Vomiting / Q000139:chemically induced*
chemical_list: D014801:Vitamin A